去乙醯毛花苷注射液市場報告：2031 年趨勢、預測與競爭分析

由於醫院和診所市場機會的推動，全球去乙醯毛花苷注射劑市場前景光明。預計2025年至2031年期間，全球去乙醯毛花苷注射劑市場的複合年成長率將達到4.5%。該市場的主要促進因素包括心臟衰竭盛行率的上升、強心配配糖體需求的增加以及老年人口的成長。

• Lucintel 預測，依類型學名藥在預測期內將出現高速成長。
• 依用途類型來看，醫院預計將實現更高的成長。
• 依地區分類，預計亞太地區將在預測期內實現最高成長。

毛花苷注射液市場新趨勢

去甲毛花苷注射劑市場正引領臨床實務和藥物研發的持續發展。儘管其作用已得到充分認可，但新興趨勢反映出人們正在不斷努力最佳化去甲毛花苷的使用，應對其獨特的挑戰，並探索潛在的新型應用，尤其是在心血管疾病管理和藥物再利用領域。

• 最佳化劑量和監測：為了盡量縮小去乙醯毛花苷的治療指數，降低副作用的風險，確保更安全的臨床應用，仍然需要注重精確的劑量調整和加強病患監測，包括電解質水平和腎功能。
• 重視急性心臟衰竭的治療：去甲毛花苷注射液在嚴重鬱血性心臟衰竭衰竭的急性治療中發揮重要作用，尤其是在需要快速起效的情況下。這一趨勢凸顯了去甲毛花苷在急診循環系統中的持續重要性。
• 腫瘤學再利用：新研究表明，去乙醯毛花苷與其他配糖體一樣，可能具有抗癌活性。這一趨勢探索了去乙醯毛花苷在前列腺癌和其他惡性腫瘤治療中的應用潛力，為其在傳統心臟適應症之外的市場成長開闢了新的途徑。
• 新劑型的開發：儘管除毛花苷主要為注射液，但也存在開發新劑型和輸送系統的機會，包括提高生物有效性的舌下或頰片，或可以提高患者便利性和依從性的緩釋性。
• 融入數位健康平台：遠端監控和遠端醫療等數位健康技術在心血管疾病管理中的日益普及，或將為去乙醯毛花苷帶來新的機會。融入這些平台或將提升患者的參與度和依從性，從而支持去乙醯毛花苷的持續使用。

這些趨勢正在重塑除毛苷注射市場，一方面鞏固了除毛苷在急性護理領域的利基市場，另一方面也謹慎地探索新的治療途徑。在新藥不斷湧現的背景下，對安全性、更優的給藥方式和再利用潛力的關注，確保了除毛苷在製藥業專業且持續的市場地位。

去乙醯毛花苷注射液市場近期趨勢

循環系統醫學的廣泛發展以及去乙醯毛花苷在某些心臟疾病中的持續效用推動了去乙醯毛花苷注射劑市場的發展。這些發展的重點在於，在新療法不斷湧現的情況下，確保其安全有效使用，解決供應鏈穩定性問題，並探索超越傳統適應症的藥理特性。

• 急性心臟病護理的持續需求：去甲毛花苷注射液仍然是治療急性鬱血性心臟衰竭衰竭和某些類型的突發性心律不整的重要藥物，特別是在快速干涉至關重要的情況下，導致急診和重症加護中的持續需求。
• 重點緩解藥品短缺：鑑於除毛苷注射液在急性病環境中的重要性，以及為了確保患者能夠持續獲得藥物，持續專注於預防和管理潛在的藥物短缺，這對於較老、盈利較低的藥品來說通常是一個挑戰。
• 抗癌活性：近期研究正積極探索去乙醯毛花苷作為抗癌藥物的潛力，尤其是在前列腺癌細胞。這項藥物再利用研究代表著在探索心臟作用以外的全新治療應用方面取得的重要進展。
• 強調藥物安全檢測警戒：由於脫毛苷的治療指數較窄，且有藥物交互作用和副作用的可能性，因此在臨床實務中強調藥物安全檢測和仔細的病患監測，以確保安全用藥。
• 最佳化全球供應鏈：製造商和經銷商正在努力最佳化除毛苷注射液的全球供應鏈，以確保不同地區的持續供應，特別是在經常將其用作心臟急救藥物的國家。

這些發展共同影響著去乙醯毛花苷注射液市場，鞏固了其在急性護理中的地位，同時也積極探索新的治療可能性。對安全性、供應鏈穩定性和藥物再利用的關注，確保了去乙醯毛花苷注射液在心血管治療領域持續發展，並保持其重要性。

目錄

第1章執行摘要

第2章 市場概述

• 背景和分類
• 供應鏈

第3章：市場趨勢與預測分析

• 宏觀經濟趨勢與預測
• 產業驅動力與挑戰
• PESTLE分析
• 專利分析
• 法規環境

第4章 去乙醯毛花苷注射液市場（依類型）

• 概述
• 依類型進行吸引力分析
• 原始藥物：趨勢與預測（2019-2031）
• 學名藥：趨勢與預測（2019-2031）

5. 全球去乙醯毛花苷注射液市場（依應用）

• 概述
• 依用途進行吸引力分析
• 醫院：趨勢與預測（2019-2031）
• 診所：趨勢與預測（2019-2031）
• 其他：趨勢與預測（2019-2031）

第6章區域分析

• 概述
• 全球去乙醯毛花苷注射液市場（依地區）

7. 北美除毛苷注射液市場

• 概述
• 北美去乙醯毛花苷注射劑市場（依類型）
• 北美去乙醯毛花苷注射液市場應用狀況
• 美國去乙醯毛花苷注射液市場
• 墨西哥的去乙醯毛花苷注射劑市場
• 加拿大去乙醯毛花苷注射液市場

8. 歐洲去乙醯毛花苷注射液市場

• 概述
• 歐洲去乙醯毛花苷注射劑市場（依類型）
• 歐洲去乙醯毛花苷注射液市場（依應用）
• 德國去乙醯毛花苷注射液市場
• 法國去乙醯毛花苷注射劑市場
• 西班牙去乙醯毛花苷注射劑市場
• 義大利去乙醯毛花苷注射劑市場
• 英國去乙醯毛花苷注射液市場

9. 亞太地區毛花苷注射劑市場

• 概述
• 亞太地區去乙醯毛花苷注射液市場（依類型）
• 亞太地區去乙醯毛花苷注射液市場應用情況
• 日本去乙醯毛花苷注射液市場
• 印度去乙醯毛花苷注射液市場
• 中國毛花苷注射液市場
• 韓國去乙醯毛花苷注射液市場
• 印尼去乙醯毛花苷注射劑劑市場

第10章 世界其他地區去乙醯毛花苷注射液市場

• 概述
• 世界其他地區去乙醯毛花苷注射液市場（依類型）
• 世界其他地區去乙醯毛花苷注射液市場（依應用）
• 中東去乙醯毛花苷注射液市場
• 南美洲除毛苷注射液市場
• 非洲去乙醯毛花苷注射液市場

第11章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析
  • 競爭對手之間的競爭
  • 買方的議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 新進入者的威脅
• 市場佔有率分析

第12章機會與策略分析

• 價值鏈分析
• 成長機會分析
  • 依類型分類的成長機會
  • 依應用分類的成長機會
• 全球去乙醯毛花苷注射液市場的新趨勢
• 戰略分析
  • 新產品開發
  • 認證和許可
  • 合併、收購、協議、合作和合資企業

第13章：價值鏈主要企業的公司簡介

• Competitive Analysis
• ShanghaizhaoHui Pharmaceutical
• Shanghai Xudong Haipu Pharmaceutical
• Chengdu Brilliant Pharmaceutical
• Viwit Pharmaceuticals
• Ryvis Pharma

第14章 附錄

• 圖表目錄
• 表格列表
• 調查方法
• 免責聲明
• 版權
• 簡稱和技術單位
• 關於美國
• 美國調查

The future of the global deslanoside injection market looks promising with opportunities in the hospital and clinic markets. The global deslanoside injection market is expected to grow with a CAGR of 4.5% from 2025 to 2031. The major drivers for this market are the increasing prevalence of heart failure, the rising demand for cardiac glycosides, and the growing elderly patient population.

• Lucintel forecasts that, within the type category, generic drug is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Deslanoside Injection Market

The deslanoside injection market is navigating a landscape of evolving clinical practices and pharmaceutical advancements. Despite its established role, emerging trends reflect a continuous effort to optimize its use, address inherent challenges, and explore potential new applications, particularly in the context of cardiovascular disease management and drug repurposing.

• Optimized Dosage and Monitoring: There is a continued focus on precise dosage adjustment and enhanced patient monitoring, including electrolyte levels and renal function, to minimize deslanoside's narrow therapeutic index and reduce the risk of adverse effects, ensuring safer clinical application.
• Emphasis on Acute Heart Failure Management: Deslanoside injection maintains its critical role in the acute management of severe congestive heart failure, particularly when rapid onset of action is required. This trend highlights its continued relevance in emergency cardiology.
• Drug Repurposing for Oncology: Emerging research suggests deslanoside, like other cardiac glycosides, may exhibit anticancer activity. This trend explores its potential repurposing for prostate cancer and other malignancies, offering a novel avenue for market growth beyond its traditional cardiac indications.
• Development of Novel Formulations: While primarily an injectable, opportunities exist for developing novel formulations and delivery systems for deslanoside. This could include sublingual or buccal tablets to improve bioavailability or sustained-release options, potentially enhancing patient convenience and adherence.
• Integration into Digital Health Platforms: The increasing adoption of digital health technologies, such as remote monitoring and telemedicine, in cardiovascular disease management could create new opportunities for deslanoside. Integration into these platforms could improve patient engagement and adherence, supporting its continued use.

These trends are collectively reshaping the deslanoside injection market by reinforcing its niche in acute care, while cautiously exploring new therapeutic avenues. The focus on safety, improved delivery, and potential repurposing, amidst a landscape of newer drugs, ensures its continued, albeit specialized, presence in the pharmaceutical industry.

Recent Developments in the Deslanoside Injection Market

The deslanoside injection market has seen recent developments driven by its ongoing utility in specific cardiac conditions, alongside the broader evolution of cardiovascular medicine. These advancements focus on ensuring its safe and effective use, addressing supply chain stability, and exploring its pharmacological properties beyond its traditional indications, despite the advent of newer therapeutic agents.

• Sustained Demand in Acute Cardiac Care: Deslanoside injection continues to be a vital medication for acute congestive heart failure and certain rapid arrhythmias, especially where prompt intervention is critical. This sustains its demand in emergency and critical care settings.
• Focus on Drug Shortage Mitigation: Given its importance in acute situations, there is an ongoing focus on preventing and managing potential drug shortages of deslanoside injection, often a challenge for older, less profitable medications, to ensure continuous patient access.
• Research into Anticancer Properties: Recent studies are actively investigating deslanoside's potential as an anticancer agent, particularly in prostate cancer cells. This research into drug repurposing represents a significant development, exploring new therapeutic applications beyond its cardiac effects.
• Emphasis on Pharmacovigilance: Due to deslanoside's narrow therapeutic index and potential for drug interactions and adverse effects, there is a heightened emphasis on pharmacovigilance and careful patient monitoring in clinical practice to ensure its safe administration.
• Global Supply Chain Optimization: Manufacturers and distributors are working to optimize global supply chains for deslanoside injection, ensuring consistent availability across different regions, particularly in countries where it remains a frequently used cardiac emergency drug.

These developments are collectively impacting the deslanoside injection market by solidifying its role in acute care, while cautiously exploring new therapeutic potential. The emphasis on safety, supply chain stability, and drug repurposing ensures its ongoing relevance, even as the cardiovascular treatment landscape continues to evolve.

Strategic Growth Opportunities in the Deslanoside Injection Market

The deslanoside injection market, while mature, presents strategic growth opportunities by focusing on its unique pharmacological properties and addressing specific clinical needs. By leveraging its rapid onset and established efficacy in acute settings, alongside exploring novel therapeutic avenues, manufacturers can ensure its continued relevance and potentially expand its market footprint in a competitive landscape.

• Acute Decompensated Heart Failure: Capitalizing on deslanoside's rapid inotropic effect for intravenous administration in acute decompensated heart failure is a key growth opportunity, particularly in emergency and critical care settings where immediate improvement in cardiac function is paramount.
• Rapid Ventricular Rate Control in Atrial Fibrillation: For patients with rapid ventricular response in atrial fibrillation where other agents are contraindicated or ineffective, deslanoside injection offers a valuable growth opportunity due to its ability to quickly slow the heart rate and improve hemodynamics.
• Repurposing in Oncology (e.g., Prostate Cancer): Pursuing clinical trials and research for deslanoside's potential anticancer effects, especially against prostate cancer cells, represents a significant growth opportunity for drug repurposing, potentially opening entirely new therapeutic markets for the drug.
• Role in Resource-Limited Settings: In developing economies or resource-limited settings where newer, more expensive cardiovascular drugs may not be readily available, deslanoside's cost-effectiveness and established efficacy for acute conditions present a vital growth opportunity for essential medicine provision.
• Niche Use in Pediatric Cardiology: While requiring careful dosing, deslanoside may find specific, though limited, growth opportunities in pediatric cardiology for certain acute heart failure or arrhythmia conditions in children, where its rapid action can be clinically advantageous.

These strategic growth opportunities are impacting the deslanoside injection market by reinforcing its critical role in acute care settings and exploring promising new therapeutic avenues. By focusing on these specific applications, manufacturers can ensure its continued demand, contribute to public health, and potentially expand its overall market value.

Deslanoside Injection Market Driver and Challenges

The deslanoside injection market is influenced by a blend of drivers supporting its continued use and significant challenges impeding broader expansion. Major drivers include its rapid action in acute cardiac emergencies and its established clinical efficacy. However, the market faces hurdles such as its narrow therapeutic window, the risk of drug interactions, and the emergence of newer, often safer, cardiovascular drugs.

The factors responsible for driving the deslanoside injection market include:

1. Rapid Onset of Action: Deslanoside's quick onset of action when administered intravenously makes it invaluable for managing acute cardiac emergencies, such as severe congestive heart failure, where immediate therapeutic effect is crucial for patient stabilization.

2. Established Clinical Efficacy: Despite the development of newer drugs, deslanoside has a long history of proven efficacy in improving myocardial contractility and controlling ventricular rates in specific cardiac arrhythmias, maintaining its clinical relevance.

3. Affordability and Accessibility (in some regions): As an older, generic drug, deslanoside injection is often more affordable and readily accessible compared to newer, patented cardiovascular medications, particularly in developing economies, driving its continued use.

4. Use in Specific Clinical Scenarios: Deslanoside remains a valuable option in specific clinical scenarios where other treatments might be ineffective or contraindicated, ensuring its continued demand as a niche, yet essential, therapeutic agent.

5. Global Burden of Cardiovascular Diseases: The increasing global prevalence of cardiovascular diseases, including heart failure and arrhythmias, contributes to an underlying demand for various cardiac medications, including deslanoside for acute management.

Challenges in the deslanoside injection market are:

1. Narrow Therapeutic Index and Toxicity Risk: Deslanoside has a very narrow therapeutic window, meaning the effective dose is close to the toxic dose. This necessitates careful monitoring and dosage adjustment, increasing the risk of adverse effects and limiting its widespread use.

2. Drug Interactions and Adverse Effects: Deslanoside is prone to numerous drug interactions with commonly prescribed medications and can cause significant adverse effects, including arrhythmias and gastrointestinal issues, requiring meticulous patient management.

3. Competition from Newer, Safer Drugs: The market faces significant competition from a wide range of newer cardiovascular drugs (e.g., beta-blockers, ACE inhibitors, ARBs) that often offer a broader therapeutic window, fewer side effects, and more convenient dosing, leading to a decline in deslanoside's overall market share.

The market is driven by its acute efficacy and affordability, securing its place in specific cardiac emergencies. However, its narrow therapeutic index, interaction risks, and competition from newer drugs present significant challenges. Sustained market presence hinges on careful clinical application and ongoing efforts to address its inherent limitations.

List of Deslanoside Injection Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies deslanoside injection companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the deslanoside injection companies profiled in this report include-

• ShanghaizhaoHui Pharmaceutical
• Shanghai Xudong Haipu Pharmaceutical
• Chengdu Brilliant Pharmaceutical
• Viwit Pharmaceuticals
• Ryvis Pharma

Deslanoside Injection Market by Segment

The study includes a forecast for the global deslanoside injection market by type, application, and region.

Deslanoside Injection Market by Type [Value from 2019 to 2031]:

• Original Drug
• Generic Drug

Deslanoside Injection Market by Application [Value from 2019 to 2031]:

• Hospital
• Clinic
• Others

Deslanoside Injection Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Deslanoside Injection Market

The deslanoside injection market, primarily used for acute congestive heart failure and cardiac arrhythmias, is experiencing evolving dynamics. While newer cardiovascular drugs have emerged, deslanoside retains a niche due to its rapid onset and specific mechanism of action. Recent developments across major economies reflect shifts in clinical practice, manufacturing focus, and ongoing challenges related to its inherent properties and therapeutic alternatives.

• United States: The US market for deslanoside injection sees its use driven by acute cardiac emergencies and specific guidelines. Recent developments include continued careful monitoring for adverse effects and drug interactions due to its narrow therapeutic index, and a focus on maintaining supply chain stability for this essential, albeit specialized, medication, amidst a broader shift to newer cardiovascular treatments.
• China: China's deslanoside injection market is influenced by its large patient population and domestic pharmaceutical production capabilities. Recent developments include a focus on ensuring local production and supply of essential medicines, and a growing emphasis on managing drug shortages which can impact the availability of older, low-cost drugs like deslanoside, despite their clinical utility.
• Germany: The German market for deslanoside injection aligns with its strong healthcare infrastructure and emphasis on high-quality pharmaceuticals. Recent developments include its continued use in specific acute cardiac settings, alongside a broader trend of increasing R&D in the pharmaceutical sector and rising prevalence of chronic diseases, though newer treatments often take precedence.
• India: India's deslanoside injection market is characterized by increasing local production and a growing healthcare sector. Recent developments include efforts to ensure the availability of essential cardiac medications, and an expanding focus on managing cardiovascular diseases, driving demand for various treatments, including deslanoside for acute situations, as part of its extensive healthcare system.
• Japan: Japan's market for deslanoside injection is shaped by its advanced healthcare system and stringent quality control. Recent developments likely include adherence to its pharmacopoeia standards for quality assurance, and a focus on clinical efficacy and patient safety given its potent nature, while research may explore its role in specific cardiac conditions.

Features of the Global Deslanoside Injection Market

• Market Size Estimates: Deslanoside injection market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Deslanoside injection market size by type, application, and region in terms of value ($B).
• Regional Analysis: Deslanoside injection market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the deslanoside injection market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the deslanoside injection market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the deslanoside injection market by type (original drug and generic drug), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Deslanoside Injection Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Original Drug: Trends and Forecast (2019-2031)
• 4.4 Generic Drug: Trends and Forecast (2019-2031)

5. Global Deslanoside Injection Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital: Trends and Forecast (2019-2031)
• 5.4 Clinic: Trends and Forecast (2019-2031)
• 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Deslanoside Injection Market by Region

7. North American Deslanoside Injection Market

• 7.1 Overview
• 7.2 North American Deslanoside Injection Market by Type
• 7.3 North American Deslanoside Injection Market by Application
• 7.4 United States Deslanoside Injection Market
• 7.5 Mexican Deslanoside Injection Market
• 7.6 Canadian Deslanoside Injection Market

8. European Deslanoside Injection Market

• 8.1 Overview
• 8.2 European Deslanoside Injection Market by Type
• 8.3 European Deslanoside Injection Market by Application
• 8.4 German Deslanoside Injection Market
• 8.5 French Deslanoside Injection Market
• 8.6 Spanish Deslanoside Injection Market
• 8.7 Italian Deslanoside Injection Market
• 8.8 United Kingdom Deslanoside Injection Market

9. APAC Deslanoside Injection Market

• 9.1 Overview
• 9.2 APAC Deslanoside Injection Market by Type
• 9.3 APAC Deslanoside Injection Market by Application
• 9.4 Japanese Deslanoside Injection Market
• 9.5 Indian Deslanoside Injection Market
• 9.6 Chinese Deslanoside Injection Market
• 9.7 South Korean Deslanoside Injection Market
• 9.8 Indonesian Deslanoside Injection Market

10. ROW Deslanoside Injection Market

• 10.1 Overview
• 10.2 ROW Deslanoside Injection Market by Type
• 10.3 ROW Deslanoside Injection Market by Application
• 10.4 Middle Eastern Deslanoside Injection Market
• 10.5 South American Deslanoside Injection Market
• 10.6 African Deslanoside Injection Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Deslanoside Injection Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 ShanghaizhaoHui Pharmaceutical
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Shanghai Xudong Haipu Pharmaceutical
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Chengdu Brilliant Pharmaceutical
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Viwit Pharmaceuticals
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Ryvis Pharma
  • Company Overview
  • Deslanoside Injection Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us

List of Figures

• Figure 1.1: Trends and Forecast for the Global Deslanoside Injection Market
• Figure 2.1: Usage of Deslanoside Injection Market
• Figure 2.2: Classification of the Global Deslanoside Injection Market
• Figure 2.3: Supply Chain of the Global Deslanoside Injection Market
• Figure 2.4: Driver and Challenges of the Deslanoside Injection Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Deslanoside Injection Market ($B) by Type
• Figure 4.3: Forecast for the Global Deslanoside Injection Market ($B) by Type
• Figure 4.4: Trends and Forecast for Original Drug in the Global Deslanoside Injection Market (2019-2031)
• Figure 4.5: Trends and Forecast for Generic Drug in the Global Deslanoside Injection Market (2019-2031)
• Figure 5.1: Global Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Deslanoside Injection Market ($B) by Application
• Figure 5.3: Forecast for the Global Deslanoside Injection Market ($B) by Application
• Figure 5.4: Trends and Forecast for Hospital in the Global Deslanoside Injection Market (2019-2031)
• Figure 5.5: Trends and Forecast for Clinic in the Global Deslanoside Injection Market (2019-2031)
• Figure 5.6: Trends and Forecast for Others in the Global Deslanoside Injection Market (2019-2031)
• Figure 6.1: Trends of the Global Deslanoside Injection Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Deslanoside Injection Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Deslanoside Injection Market (2019-2031)
• Figure 7.2: North American Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 7.5: North American Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Deslanoside Injection Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Deslanoside Injection Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Deslanoside Injection Market (2019-2031)
• Figure 8.2: European Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 8.5: European Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Deslanoside Injection Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Deslanoside Injection Market (2019-2031)
• Figure 9.2: APAC Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Deslanoside Injection Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Deslanoside Injection Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Deslanoside Injection Market (2019-2031)
• Figure 10.2: ROW Deslanoside Injection Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Deslanoside Injection Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Deslanoside Injection Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Deslanoside Injection Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Deslanoside Injection Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Deslanoside Injection Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Deslanoside Injection Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Deslanoside Injection Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Deslanoside Injection Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Deslanoside Injection Market
• Figure 11.2: Market Share (%) of Top Players in the Global Deslanoside Injection Market (2024)
• Figure 12.1: Growth Opportunities for the Global Deslanoside Injection Market by Type
• Figure 12.2: Growth Opportunities for the Global Deslanoside Injection Market by Application
• Figure 12.3: Growth Opportunities for the Global Deslanoside Injection Market by Region
• Figure 12.4: Emerging Trends in the Global Deslanoside Injection Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Deslanoside Injection Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Deslanoside Injection Market by Region
• Table 1.3: Global Deslanoside Injection Market Parameters and Attributes
• Table 3.1: Trends of the Global Deslanoside Injection Market (2019-2024)
• Table 3.2: Forecast for the Global Deslanoside Injection Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Deslanoside Injection Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Deslanoside Injection Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Deslanoside Injection Market (2025-2031)
• Table 4.4: Trends of Original Drug in the Global Deslanoside Injection Market (2019-2024)
• Table 4.5: Forecast for Original Drug in the Global Deslanoside Injection Market (2025-2031)
• Table 4.6: Trends of Generic Drug in the Global Deslanoside Injection Market (2019-2024)
• Table 4.7: Forecast for Generic Drug in the Global Deslanoside Injection Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Deslanoside Injection Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Deslanoside Injection Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Deslanoside Injection Market (2025-2031)
• Table 5.4: Trends of Hospital in the Global Deslanoside Injection Market (2019-2024)
• Table 5.5: Forecast for Hospital in the Global Deslanoside Injection Market (2025-2031)
• Table 5.6: Trends of Clinic in the Global Deslanoside Injection Market (2019-2024)
• Table 5.7: Forecast for Clinic in the Global Deslanoside Injection Market (2025-2031)
• Table 5.8: Trends of Others in the Global Deslanoside Injection Market (2019-2024)
• Table 5.9: Forecast for Others in the Global Deslanoside Injection Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Deslanoside Injection Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Deslanoside Injection Market (2025-2031)
• Table 7.1: Trends of the North American Deslanoside Injection Market (2019-2024)
• Table 7.2: Forecast for the North American Deslanoside Injection Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Deslanoside Injection Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Deslanoside Injection Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Deslanoside Injection Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Deslanoside Injection Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Deslanoside Injection Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Deslanoside Injection Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Deslanoside Injection Market (2019-2031)
• Table 8.1: Trends of the European Deslanoside Injection Market (2019-2024)
• Table 8.2: Forecast for the European Deslanoside Injection Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Deslanoside Injection Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Deslanoside Injection Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Deslanoside Injection Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Deslanoside Injection Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Deslanoside Injection Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Deslanoside Injection Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Deslanoside Injection Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Deslanoside Injection Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Deslanoside Injection Market (2019-2031)
• Table 9.1: Trends of the APAC Deslanoside Injection Market (2019-2024)
• Table 9.2: Forecast for the APAC Deslanoside Injection Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Deslanoside Injection Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Deslanoside Injection Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Deslanoside Injection Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Deslanoside Injection Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Deslanoside Injection Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Deslanoside Injection Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Deslanoside Injection Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Deslanoside Injection Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Deslanoside Injection Market (2019-2031)
• Table 10.1: Trends of the ROW Deslanoside Injection Market (2019-2024)
• Table 10.2: Forecast for the ROW Deslanoside Injection Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Deslanoside Injection Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Deslanoside Injection Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Deslanoside Injection Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Deslanoside Injection Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Deslanoside Injection Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Deslanoside Injection Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Deslanoside Injection Market (2019-2031)
• Table 11.1: Product Mapping of Deslanoside Injection Suppliers Based on Segments
• Table 11.2: Operational Integration of Deslanoside Injection Manufacturers
• Table 11.3: Rankings of Suppliers Based on Deslanoside Injection Revenue
• Table 12.1: New Product Launches by Major Deslanoside Injection Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Deslanoside Injection Market